Glaxosmithkline (GSK)

 

GSK Share PerformanceMore

52 week high1,724.5 22/06/17
52 week low1,444.0 19/09/17
52 week change -142.0 (-8.53%)
4 week volume156,377,613 26/09/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director/PDMR Shareholding

RNS Number: 2490U GlaxoSmithKline PLC 20 October 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr B McNamara b) Position/status CEO, Consumer Healthcare c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market pa...

Director/PDMR Shareholding

RNS Number: 2483U GlaxoSmithKline PLC 20 October 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr N Hirons b) Position/status SVP, Global Ethics & Compliance c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market p...

Director Deals - GlaxoSmithKline PLC (GSK)

Dr Patrick Vallance, Executive Director, has re-invested 9,295 shares in the company on the 12th October 2017 at a price of...

Director Deals - GlaxoSmithKline PLC (GSK)

Simon Dingemans, Financial Director, has re-invested 8,087 shares in the company on the 12th October 2017 at a price of 15...

Director Deals - GlaxoSmithKline PLC (GSK)

Emma Walmsley, Chief Executive Officer, has re-invested 9,617 shares in the company on the 12th October 2017 at a price ...

Director/PDMR Shareholding

RNS Number: 7388T GlaxoSmithKline PLC 16 October 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participa...

Director/PDMR Shareholding

RNS Number: 7382T GlaxoSmithKline PLC 16 October 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Dr S Dexter b) Position/status PCA of Dr P J T Vallance (President, R&D) c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance m...

Director/PDMR Shareholding

RNS Number: 7369T GlaxoSmithKline PLC 16 October 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr D E Troy b) Position/status SVP & General Counsel c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant,...

Fundamental DataMore

P/E ratio81.037
EPS18.8
Dividend yield5.251 %

Latest discussion posts More

  • The Bottom of Governance

    This was published fairly recently. GSK came 103rd in the Institute of Director's 2017 third annual Good Governance Index (GGI) report. GSK was the worst of FTSE 100 ...
    19-Oct-2017
    bloppy
  • GSK mine failed trial data with Supercomputers

    Interesting insight into some of the initiatives being tried under Walmsley's leadership, if successful it might release significant value out previous investments. H2 ...
    18-Oct-2017
    Hydrogen Economy
  • ?Hold? onto Glaxo on inhaler trial success, says Deutsche

    ?Hold? onto Glaxo on inhaler trial success, says Deutsche Trial success for GlaxoSmithKline?s (GSK) triple therapy inhaler should assuage fears over generic competition to the ...
    22-Sep-2017
    IOMINVESTCOM

Users' HoldingsMore

Users who hold Glaxosmithkline also hold..
VODAFONE GRP.35%
BP34%
NATIONAL GRID32%
LLOYDS GRP.32%
RDS 'B'31%

Codes & Symbols

ISINGB0009252882
SymbolsGSK, LSE:GSK, GSK.L, GSK:LN, LON:GSK, XLON:GSK